The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter.
UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...
The company didn’t disclose the planned price of the generic, noting only that it “will cost less than branded Victoza.” The branded drug costs between $500 and $815 per package, depending on the ...
The company didn’t disclose the planned price of the generic, noting only that it “will cost less than branded Victoza.” The branded drug costs between $500 and $815 per package, depending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback